期刊文献+

HE4、CA125和CA199联合D-二聚体检测在卵巢癌早期诊断中的应用 被引量:20

Combined detection of HE4,CA125,CA199 and D-dimer in the early diagnosis of ovarian cancer
原文传递
导出
摘要 目的探讨人附睾分泌蛋白4(HE4)、糖类抗原125(CA125)和糖类抗原199(CA199)联合血浆D-二聚体检测在卵巢癌早期诊断中的应用价值。方法选取2014年1月至2017年12月间上海市金山区亭林医院收治的50例确诊卵巢癌患者为癌症组,50例良性卵巢肿瘤患者为良性组,另选取同期50例健康体检女性为对照组,采用化学发光法测定三组受试者血清HE4、CA125和CA199的水平,采用免疫比浊法测定血浆D-二聚体水平,分析四项指标水平对卵巢癌早期诊断价值。结果癌症组患者HE4、CA125、CA199及D-二聚体水平均高于良性组和对照组,差异均有统计学意义(均P <0. 05)。癌症组患者HE4、CA125、CA199、D-二聚体及联合检测阳性率均高于良性组和对照组,差异均有统计学意义(均P <0. 05)。单项检测中,HE4敏感性、特异性、阳性预测值、阴性预测值及诊断效率最高;联合检测敏感性、特异性、阳性预测值、阴性预测值及诊断效率均高于单项检测。结论 HE4、CA125、CA199和D-二聚体联合检测可提高卵巢癌早期诊断效率,对卵巢癌的早期诊断和治疗有重要临床价值。 Objective To explore the clinical value of combined detection of human epididymis protein4( HE4),carbohydrate antigen199( CA199),carbohydrate antigen125( CA125) and D-dimer in the early diagnosis of ovarian cancer. Methods Fifty patients with ovarian cancer( cancer group) and 50 patients with benign ovarian tumors( benign group) admitted to Tinglin Hospital of Jinshan District from January 2014 to December 2017 were selected. Another 50 healthy women( control group) were selected at the same time. The serum levels of HE4,CA125 and CA199 were determined by using chemiluminescent immunoassay among the three groups. The serum levels of D-dimer were determined by using immunoassay.Significance of the above four indexes for the early diagnosis of ovarian cancer was analyzed. Results The serum levels of HE4,CA199,CA125 and D-dimer in the ovarian cancer group were higher than in the benign group and control group( all P < 0. 05). The positive rate of HE4,CA199,CA125 and D-dimer in cancer group was significantly higher than in the benign group and the control group( all P < 0. 05). The sensitivity,specificity,positive predictive value,negative predictive value and diagnostic efficiency of HE4 were the highest among the four tests. The sensitivity,specificity,positive predictive value,negative predictive value and diagnostic efficiency of the four combined tests were higher than the single test,and the difference was statistically significant( all P < 0. 05). Conclusion The combined detection of HE4,CA125,CA199 and D-dimer can improve the efficiency of early diagnosis for ovarian cancer,which has important clinical value for early diagnosis and treatment of ovarian cancer.
作者 马爱矿 高华丽 王敏 王晓蓉 MA Ai-kuang;GAO Hua-li;WANG Min;WANG Xiao-rong(Department of Clinical Laboratory, Shanghai Electric Power Hospital, Shanghai 200050, China;Department of Clinical Laboratory, Tinglin Hospital, Jinshan District, Shanghai 201505 , China)
出处 《中国肿瘤临床与康复》 2019年第7期793-795,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 HE4 CA125 CA199 D-二聚体 卵巢肿瘤 联合检测 HE4 CA125 CA199 D-dimer Ovarian neoplasms Combined detection
  • 相关文献

参考文献9

二级参考文献93

  • 1邵丽佳,徐瑞龙,胡轶.血清CA125、CA199、CEA单检及联检对诊断卵巢癌的临床价值[J].放射免疫学杂志,2007,20(1):92-93. 被引量:25
  • 2Igor B, Borut G. Preperative value of CA125 as a reflection of tumor grade in epitheliai ovarian cancer. Gynecal Oncal. 1996, 63:166.
  • 3Friedlander ML. Prognostic factors in ovarian cancer. Semin Oncol. 1998, 25:305.
  • 4Jaeger W, Ackermann S, Kessler H, et al.The effect of bowel resection on survival in advance epithelial ovarian cancer. Gynecol Oncol. 2001, 83(6) : 286.
  • 5Mann DV, Edwards R, Ho S, et al.Elevated tumor marker CA 199:Clinical interpretation and influence of obstructive jaundice[J].Eur J Surg Ocol, 2000, 26: 474-479.
  • 6Moss El, Hollingworth J.The role of CA125 in clinical practice [J]. Clin Pathol, 2005, 58 ( 3 ):308-312.
  • 7Norum LF, Erikstein B, Nustad K.Elevated CA125 in breastCancer-A Sign of advanced disease[J]. Tumour Biol, 2001, 22 (4):223-228.
  • 8Ishigami S, Natsugoe S, Hokita S, et al.Clinieal importance of preopretive eareinoembryonie antigen and carbohydrate antigen 199 levels in gastrie eaneer[J].J Clin Gastro, 2001, 32 ( 1 ):41-44.
  • 9Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [J].CA Cancer J Clin, 2009,59 (4) : 225-249.
  • 10Gubbels J,Claussen N, Kapur AK, et al. The detection, treatment and biology of epithelial ovarian cancer[J]. J O- varian Res, 2010,3 (8) : 1-11.

共引文献126

同被引文献189

引证文献20

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部